Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer
NCT00003669
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Endometrial Cancer
Interventions
DRUG:
arzoxifene hydrochloride
Sponsor
Eli Lilly and Company